The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
{{output}}
Introduction: Recent randomized trials have demonstrated the efficacy of ibrutinib-based therapy in the treatment of patients with CLL. In Alliance A041202, a higher than expected number of unexplained deaths were reported with f... ...
